Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gynecomastia demonstrated on the bone scan

D R Brill

    The Journal of Urology
    |July 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Gynecomastia in prostate cancer patients on diethylstilbestrol therapy can mimic rib metastases on bone scans. Increased isotope uptake in hypertrophic breasts may be mistaken for bone lesions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Procedure guideline for hepatobiliary scintigraphy. Society of Nuclear Medicine.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1997
    Same author

    How to be an effective risk communicator.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
    Same author

    How to be an effective risk communicator--Part 1.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1996
    Same author

    Managing wastes in Pennsylvania.

    Pennsylvania medicine·1993
    Same author

    Possible health effects of EMF.

    Pennsylvania medicine·1992
    Same author

    Disposal of low-level radioactive waste.

    Investigative radiology·1991

    Area of Science:

    • Nuclear medicine
    • Oncology
    • Endocrinology

    Background:

    • Diethylstilbestrol (DES) is used to treat prostate cancer.
    • Gynecomastia is a known side effect of DES therapy.
    • Bone scans are used to detect bone metastases.

    Observation:

    • Two patients with prostate cancer developed gynecomastia due to DES therapy.
    • Bone scans were performed to rule out bone metastases.
    • Increased technetium-99m diphosphonate uptake was observed in the breast region.

    Findings:

    • The increased isotope concentration corresponded to the location of hypertrophic breasts.
    • No evidence of bone metastases was found in either patient.
    • This finding may reflect similar radionuclide uptake in female breasts.

    Related Experiment Videos

    Implications:

    • Gynecomastia can be misinterpreted as rib metastases on bone scans.
    • Radiologists should be aware of this potential imaging artifact.
    • Distinguishing gynecomastia from metastases is crucial for accurate patient management.